FDA Releases List of Drugs Posing "Potential Safety Issues"

NEWSBRIEF: The FDA has released its first quarterly list of drugs that under investigation for posting "potential safety issues."

The list includes:

• Cymbalta (duloxetine), an antidepressant also approved for fibromyalgia
• Dilantin (phenetoin injection), an antiseizure drug
• Seroquel (quetiapine), an antipsychotic
• Tumor Necrosis Factor (TNF) Blockers, such as Enbrel (etanercept), Remicade (infliximab), and Humira (adalimumab), used for arthritis
• Humulin R (Insulin U-500), for diabetes

A drug's appearance on the list doesn't mean the FDA has found it to be dangerous, but means being examined for potential problems. The FDA has begun posting this list as part of the 2007 Food and Drug Administration Amendments Act.

• See the entire list
• Report an adverse reaction to the FDA

Related Content: Drug Treatments for Fibromyalgia & Chronic Fatigue Syndrome